65,437 trials
Dermatomyositis
Primary: Occurrence of at Least One Adverse Event — 1; 1; 5; 1 participants
Chemotherapy-Induced Nausea and Vomiting
Primary: Percentage of Patients With Complete Control — 71.4; 76.0; 90.9 Percentage
Ulcer
Primary: Number of Participants Who Develop Endoscopically-diagnosed Gastric Ulcers — 55; 52 participants — p=<0.0001
Neuralgia · Epilepsy
Primary: Percentage of Participants With a 50 Percent or Greater Reduction From Baseline in 28 Day Partial Seizure Frequency — 85.00 Percentage of participants
Human Papilloma Virus · Cervical Cancer · Vulvar Cancer
Primary: Geometric Mean Titers (GMTs) to Each of the HPV Types Contained in the Vaccine for Phase A — 1273.3; 2203.0; 4784.7; 1991.6 mMU/mL
Myopia
Primary: Distribution of Change in Spherical Equivalent Refractive Error From Baseline to 3 Years — 6; 3; 11; 8 participants
Parkinson's Disease
Primary: Change in Total Unified Parkinson's Disease Rating Scale (UPDRS) Score From Baseline — 0.9; -1.2; -0.7; 0.7 Scores on a scale — p=0.0133
Postmenopausal Osteoporosis
Primary: Percent Change From Baseline Lumbar Spine Bone Mineral Density (BMD) at Week 52 / Endpoint, ITT Population — 3.069; 3.302; 3.365 Percent Change
Glioma
Primary: Number of Participants With the Indicated Change From Baseline to Study Completion in Systolic Blood Pressure — 21; 12; 11; 12 participants
GERD · Acid Reflux Disease · Heartburn
Primary: Symptom Intensity Rated by Participants Twice Daily Using an Electronic Reflux Symptom Questionnaire Diary
Influenza
Primary: Oseltamivir Carboxylate AUC12 (Area Under the Curve). — 6; 1; 3; 0 participants
Rheumatoid Arthritis
Primary: Percentage of Subjects Without Baseline Protective Titers Achieving a ≥ 2-fold Titer Increase in ≥ 3 of 6 Pneumococcal Antigens (6B, 9V, 14, 18C, 19F, and 23F) at Week…
Parkinson's Disease · Psychotic Disorders
Primary: Patient Evaluation of Symptoms of Psychosis. — -9.8; -12.9; -9.7; -10.0 Scores on a scale — p=0.5177
Palliative Care · Pain · Cancer
Primary: Number of Patients With at Least 30% Improvement in Numerical Rating Scale (NRS) Average Pain Score From Baseline — 22; 26; 30; 24 Participants — p=0.33
Amblyopia
Primary: Distribution of Visual Acuity in the Amblyopic Eye at 24 Weeks — 1; 0; 3; 0 participants